News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
217,020 Results
Type
Article (14571)
Company Profile (22)
Press Release (202425)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (73197)
Career Advice (236)
Deals (11977)
Drug Delivery (30)
Drug Development (28895)
Employer Resources (22)
FDA (5085)
Job Trends (4848)
News (118557)
Policy (9232)
Tag
Academia (515)
Accelerated approval (4)
Adcomms (1)
Allergies (36)
Alliances (12260)
ALS (52)
Alzheimer's disease (333)
Antibody-drug conjugate (ADC) (52)
Approvals (5159)
Artificial intelligence (57)
Autoimmune disease (12)
Automation (4)
Bankruptcy (101)
Best Places to Work (3565)
BIOSECURE Act (1)
Biosimilars (39)
Biotechnology (17)
Bladder cancer (39)
Brain cancer (16)
Breast cancer (151)
Cancer (1088)
Cardiovascular disease (97)
Career advice (219)
Career pathing (2)
CAR-T (39)
CDC (9)
Cell therapy (112)
Cervical cancer (15)
Clinical research (25288)
Collaboration (217)
Compensation (210)
Complete response letters (4)
COVID-19 (695)
CRISPR (18)
C-suite (69)
Cystic fibrosis (23)
Data (1565)
Denatured (3)
Depression (25)
Diabetes (147)
Diagnostics (1689)
Digital health (8)
Diversity, equity & inclusion (2)
Drug discovery (34)
Drug pricing (14)
Drug shortages (11)
Duchenne muscular dystrophy (44)
Earnings (47760)
Editorial (15)
Employer branding (4)
Employer resources (17)
Events (29387)
Executive appointments (104)
FDA (5851)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (204)
Gene editing (31)
Generative AI (4)
Gene therapy (93)
GLP-1 (310)
Government (1003)
Grass and pollen (3)
Guidances (290)
Healthcare (4673)
HIV (21)
Huntington's disease (7)
IgA nephropathy (9)
Immunology and inflammation (55)
Immuno-oncology (3)
Indications (18)
Infectious disease (758)
Inflammatory bowel disease (43)
Influenza (18)
Intellectual property (29)
Interviews (24)
IPO (6556)
IRA (5)
Job creations (1491)
Job search strategy (207)
Kidney cancer (5)
Labor market (16)
Layoffs (154)
Leadership (2)
Legal (1961)
Liver cancer (24)
Longevity (3)
Lung cancer (192)
Lymphoma (109)
Machine learning (4)
Management (8)
Manufacturing (115)
MASH (33)
Medical device (3441)
Medtech (3444)
Mergers & acquisitions (5619)
Metabolic disorders (338)
Multiple sclerosis (36)
NASH (4)
Neurodegenerative disease (36)
Neuropsychiatric disorders (11)
Neuroscience (578)
NextGen: Class of 2025 (1582)
Non-profit (949)
Now hiring (5)
Obesity (163)
Opinion (32)
Ovarian cancer (30)
Pain (32)
Pancreatic cancer (43)
Parkinson's disease (56)
Partnered (5)
Patents (65)
Patient recruitment (51)
Peanut (17)
People (12438)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase I (6779)
Phase II (10856)
Phase III (9553)
Pipeline (1461)
Policy (16)
Postmarket research (1026)
Preclinical (2354)
Press Release (11)
Prostate cancer (52)
Psychedelics (5)
Radiopharmaceuticals (52)
Rare diseases (137)
Real estate (1877)
Recruiting (11)
Regulatory (7049)
Reports (20)
Research institute (447)
Resumes & cover letters (16)
Rett syndrome (4)
RNA editing (1)
RSV (24)
Schizophrenia (31)
Series A (30)
Series B (22)
Sickle cell disease (20)
Special edition (7)
Spinal muscular atrophy (54)
Sponsored (7)
Startups (961)
Stomach cancer (3)
Supply chain (19)
Tariffs (12)
The Weekly (3)
Vaccines (253)
Venture capital (12)
Weight loss (125)
Women's health (9)
Worklife (1)
Date
Last 7 days (183)
Last 30 days (500)
Last 365 days (8896)
2025 (6887)
2024 (10255)
2023 (11680)
2022 (13452)
2021 (15115)
2020 (13857)
2019 (10880)
2018 (7918)
2017 (28297)
2016 (35796)
2015 (8602)
2014 (5802)
2013 (3925)
2012 (4692)
2011 (5110)
2010 (4818)
Location
Africa (241)
Alabama (9)
Arizona (59)
Asia (14529)
Australia (2251)
California (2406)
Canada (874)
China (280)
Colorado (120)
Connecticut (108)
Delaware (109)
Europe (33511)
Florida (364)
Georgia (87)
Idaho (8)
Illinois (193)
India (12)
Indiana (142)
Iowa (1)
Japan (94)
Kansas (29)
Kentucky (6)
Louisiana (7)
Maine (28)
Maryland (324)
Massachusetts (1794)
Michigan (50)
Minnesota (122)
Missouri (24)
Montana (7)
Nevada (37)
New Hampshire (18)
New Jersey (836)
New Mexico (4)
New York (695)
North Carolina (335)
Northern California (1245)
Ohio (40)
Oklahoma (1)
Oregon (7)
Pennsylvania (482)
Puerto Rico (11)
Rhode Island (5)
South America (382)
South Carolina (4)
Southern California (862)
Tennessee (19)
Texas (338)
United States (8967)
Utah (71)
Virginia (42)
Washington D.C. (21)
Washington State (274)
West Virginia (1)
Wisconsin (22)
217,020 Results for "16".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vicore to Present at Pareto Securities’ 16th Annual Healthcare Conference
September 15, 2025
·
1 min read
Press Releases
Senzime to Present at Pareto Securities’ 16th Annual Healthcare Conference
September 12, 2025
·
1 min read
Press Releases
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - October 16, 2025
October 17, 2025
·
2 min read
Press Releases
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 16, 2025
October 16, 2025
·
2 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2025
October 16, 2025
·
2 min read
Press Releases
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
September 28, 2025
·
27 min read
Press Releases
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrants
October 8, 2025
·
5 min read
Press Releases
Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
September 10, 2025
·
5 min read
Press Releases
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrants
October 9, 2025
·
5 min read
Press Releases
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - September 16, 2025
September 16, 2025
·
2 min read
1 of 21,702
Next
